ID: h-var-5c12304fe5
Hypothesis

Astrocyte-Mediated Synaptic Pruning to Optimize Functional Connectome Efficiency

Astrocytes play a critical role in synaptic pruning and maintenance of neural circuits through complement-mediated elimination of weak or aberrant synaptic connections.
🧬 C1q🩺 connectomics🎯 Composite 35%💱 $0.45▲19.0%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 5 support 5 oppose
✓ All Quality Gates Passed
Mechanistic 0.49 (15%) Evidence 0.26 (15%) Novelty 0.35 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.37 (10%) Safety 0.20 (8%) Competition 0.38 (6%) Data Avail. 0.56 (5%) Reproducible 0.15 (5%) KG Connect 0.30 (8%) 0.354 composite

🧪 Overview

Astrocytes play a critical role in synaptic pruning and maintenance of neural circuits through complement-mediated elimination of weak or aberrant synaptic connections. This hypothesis proposes that targeted activation of astrocytic complement cascade, specifically through C1q upregulation and subsequent C3 tagging of synapses, can restore optimal functional connectivity patterns in disrupted neural networks. Unlike structural remyelination approaches, this mechanism focuses on refining existing synaptic architecture by selectively eliminating maladaptive connections while preserving or strengthening functionally relevant pathways. Astrocytes would identify synapses for elimination through activity-dependent monitoring of synaptic strength and frequency, using their extensive processes that contact multiple synapses simultaneously. The intervention would involve pharmacological or optogenetic activation of astrocytic complement pathways, particularly targeting the C1q-C3-microglia axis, to enhance pruning efficiency in regions showing aberrant hyperconnectivity or maintaining weak connections that impair network function.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Astrocyte C1Q<br/>Complement Expression"]
    B["C1qa C1qb C1qc<br/>Subcomponent Assembly"]
    C["Synaptic C3 Fragment<br/>Tagging"]
    D["Microglial Phagocytosis<br/>Recognition and Engulfment"]
    E["Synaptic Pruning<br/>Connectome Remodeling"]
    F["Functional Optimization<br/>Efficiency Gain"]
    G["Excessive Pruning<br/>as Pathological Driver"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    G -.->|"risk"| E
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix5 supports5 contradicts
Supports
Myelin breakdown is an early, underrecognized feature of AD pathophysiology
Supports
Hub regions connected by long-range white matter tracts that are particularly vulnerable
Supports
Clemastine promotes OPC differentiation and remyelination in cuprizone and EAE models
Supports
Siponimod (Mayzent) FDA-approved for secondary progressive MS
Supports
Network-level changes include reduced white matter integrity measurable by diffusion MRI
Contradicts
Myelin changes in AD may be secondary to axonal degeneration - primary vs secondary unresolved
Contradicts
White matter hyperintensities correlate with vascular pathology, not primary OPC dysfunction
Contradicts
Clemastine not advanced to AD clinical trials - off-target antihistamine effects
Contradicts
Siponimod failed in secondary progressive MS - S1P modulation insufficient for established myelin pathology
Contradicts
Aged human OPCs have substantially reduced differentiation capacity vs young animals
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — C1Q

No curated PDB or AlphaFold mapping for C1Q yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for C1q from GTEx v10.

Spinal cord cervical c-174.7 Substantia nigra38.2median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for C1q →

No DepMap CRISPR Chronos data found for C1q.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.6%
Volatility
Low
0.0038
Events (7d)
2
Price History
▲19.0%

💾 Resource Usage

LLM Tokens
47,826
$0.1435
Total Cost
$0.1435

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF we selectively upregulate astrocytic C1q expression using AAV-GfaABC1D-C1q viral vectors in the prefrontal cortex of adult Cntnap2−/− mice (an autism-related hyperconnectivity model), THEN we will Synaptic density will decrease by 15-25% in the prefrontal cortex, accompanied by normalized functional connectivity patterns including reduced hyperconnectivit— no observation —pending0.65
IF we apply pharmacological C1q pathway activation (small-molecule agonist) to human iPSC-derived cortical organoids co-cultured with iPSC-derived microglia, THEN synaptic pruning efficiency will incrEnhanced complement-mediated synaptic pruning will result in preferential elimination of weak synapses (lower PSD95 intensity), increased microglia-synapse cont— no observation —pending0.55
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we selectively upregulate astrocytic C1q expression using AAV-GfaABC1D-C1q viral vectors in the prefrontal cortex of adult Cntnap2−/− mice (an autism-related hyperconnectivity model), THEN we will observe a significant reduction in synaptic density (≥15% decrease in PSD95+ puncta) and improved fu
Predicted outcome: Synaptic density will decrease by 15-25% in the prefrontal cortex, accompanied by normalized functional connectivity patterns including reduced hyperc
Falsification: Synaptic density remains unchanged or increases despite C1q overexpression; functional connectivity shows no improvement or worsens; hyperconnectivity persists or amplifies; any increase in microglial
pendingconf 55%
IF we apply pharmacological C1q pathway activation (small-molecule agonist) to human iPSC-derived cortical organoids co-cultured with iPSC-derived microglia, THEN synaptic pruning efficiency will increase (≥30% reduction in synaptophysin+ areas co-localized with microglia markers) and network-level
Predicted outcome: Enhanced complement-mediated synaptic pruning will result in preferential elimination of weak synapses (lower PSD95 intensity), increased microglia-sy
Falsification: Synaptic pruning rate shows no change or decreases; network synchrony deteriorates or becomes arrhythmic; microglia exhibit increased activation markers indicating inflammatory response (TNFα, IL-1β u
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.